658 related articles for article (PubMed ID: 30391380)
1. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
Fernández J; Prado V; Trebicka J; Amoros A; Gustot T; Wiest R; Deulofeu C; Garcia E; Acevedo J; Fuhrmann V; Durand F; Sánchez C; Papp M; Caraceni P; Vargas V; Bañares R; Piano S; Janicko M; Albillos A; Alessandria C; Soriano G; Welzel TM; Laleman W; Gerbes A; De Gottardi A; Merli M; Coenraad M; Saliba F; Pavesi M; Jalan R; Ginès P; Angeli P; Arroyo V;
J Hepatol; 2019 Mar; 70(3):398-411. PubMed ID: 30391380
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.
Fernández J; Acevedo J; Castro M; Garcia O; de Lope CR; Roca D; Pavesi M; Sola E; Moreira L; Silva A; Seva-Pereira T; Corradi F; Mensa J; Ginès P; Arroyo V
Hepatology; 2012 May; 55(5):1551-61. PubMed ID: 22183941
[TBL] [Abstract][Full Text] [Related]
3. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
Merli M; Lucidi C; Di Gregorio V; Falcone M; Giannelli V; Lattanzi B; Giusto M; Ceccarelli G; Farcomeni A; Riggio O; Venditti M
PLoS One; 2015; 10(5):e0127448. PubMed ID: 25996499
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
Piano S; Singh V; Caraceni P; Maiwall R; Alessandria C; Fernandez J; Soares EC; Kim DJ; Kim SE; Marino M; Vorobioff J; Barea RCR; Merli M; Elkrief L; Vargas V; Krag A; Singh SP; Lesmana LA; Toledo C; Marciano S; Verhelst X; Wong F; Intagliata N; Rabinowich L; Colombato L; Kim SG; Gerbes A; Durand F; Roblero JP; Bhamidimarri KR; Boyer TD; Maevskaya M; Fassio E; Kim HS; Hwang JS; Gines P; Gadano A; Sarin SK; Angeli P;
Gastroenterology; 2019 Apr; 156(5):1368-1380.e10. PubMed ID: 30552895
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure.
Wong F; Piano S; Singh V; Bartoletti M; Maiwall R; Alessandria C; Fernandez J; Soares EC; Kim DJ; Kim SE; Marino M; Vorobioff J; Barea RCR; Merli M; Elkrief L; Vargas V; Krag A; Singh SP; Lesmana LA; Toledo C; Marciano S; Verhelst X; Intagliata N; Rabinowich L; Colombato L; Kim SG; Gerbes A; Durand F; Roblero JP; Bruns T; Yoon EL; Girala M; Pyrsopoulos NT; Kim TH; Yim SY; Juanola A; Gadano A; Angeli P;
J Hepatol; 2021 Feb; 74(2):330-339. PubMed ID: 32781201
[TBL] [Abstract][Full Text] [Related]
6. Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies.
Liu J; Gao Y; Wang X; Qian Z; Chen J; Huang Y; Meng Z; Lu X; Deng G; Liu F; Zhang Z; Li H; Zheng X
Yonsei Med J; 2020 Feb; 61(2):145-153. PubMed ID: 31997623
[TBL] [Abstract][Full Text] [Related]
7. New antibiotic strategies in patients with cirrhosis and bacterial infection.
Fernández J; Acevedo J
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1495-500. PubMed ID: 26465070
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms.
Addo Smith JN; Yau R; Russo HP; Putney K; Restrepo A; Garey KW; Sofjan AK
J Clin Gastroenterol; 2018 Aug; 52(7):648-654. PubMed ID: 29176351
[TBL] [Abstract][Full Text] [Related]
9. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.
Salerno F; Borzio M; Pedicino C; Simonetti R; Rossini A; Boccia S; Cacciola I; Burroughs AK; Manini MA; La Mura V; Angeli P; Bernardi M; Dalla Gasperina D; Dionigi E; Dibenedetto C; Arghittu M;
Liver Int; 2017 Jan; 37(1):71-79. PubMed ID: 27364035
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.
Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T
BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.
Zhao R; Ma J; Li P; Fang H; Sun S; Wu W; Chen J; Zhao H; Jin L; Shi Y; Sheng J
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1167-1174. PubMed ID: 30152255
[TBL] [Abstract][Full Text] [Related]
12. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis.
Prado V; Hernández-Tejero M; Mücke MM; Marco F; Gu W; Amoros A; Toapanta D; Reverter E; Peña-Ramirez C; Altenpeter L; Bassegoda O; Mezzano G; Aziz F; Juanola A; Rodríguez-Tajes S; Chamorro V; López D; Reyes M; Hogardt M; Kempf VAJ; Ferstl PG; Zeuzem S; Martínez JA; Vila J; Arroyo V; Trebicka J; Fernandez J
J Hepatol; 2022 May; 76(5):1079-1089. PubMed ID: 35074475
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.
Tandon P; Delisle A; Topal JE; Garcia-Tsao G
Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1291-8. PubMed ID: 22902776
[TBL] [Abstract][Full Text] [Related]
14. Infection in cirrhosis: A prospective study.
Bhattacharya C; Das-Mondal M; Gupta D; Sarkar AK; Kar-Purkayastha S; Konar A
Ann Hepatol; 2019; 18(6):862-868. PubMed ID: 31635968
[TBL] [Abstract][Full Text] [Related]
15. Infections complicating cirrhosis.
Piano S; Brocca A; Mareso S; Angeli P
Liver Int; 2018 Feb; 38 Suppl 1():126-133. PubMed ID: 29427501
[TBL] [Abstract][Full Text] [Related]
16. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
Huang X; Li G; Yi L; Li M; Wang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
[TBL] [Abstract][Full Text] [Related]
17. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
Allaire M; Cadranel JF; Nguyen TTN; Garioud A; Zougmore H; Heng R; Perignon C; Ollivier-Hourmand I; Dao T
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):264-274. PubMed ID: 31706985
[TBL] [Abstract][Full Text] [Related]
18. European intensive care physicians' experience of infections due to antibiotic-resistant bacteria.
Lepape A; Jean A; De Waele J; Friggeri A; Savey A; Vanhems P; Gustin MP; Monnet DL; Garnacho-Montero J; Kohlenberg A
Antimicrob Resist Infect Control; 2020; 9(1):1. PubMed ID: 31908772
[TBL] [Abstract][Full Text] [Related]
19. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
[TBL] [Abstract][Full Text] [Related]
20. The threat of carbapenem resistance in Eastern Europe in patients with decompensated cirrhosis admitted to intensive care unit.
Fischer P; Pandrea S; Dan Grigorescu M; Stefanescu H; Tefas C; Hadade A; Procopet B; Ionescu D
Dig Liver Dis; 2022 Oct; 54(10):1385-1391. PubMed ID: 35732546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
